Curriculum Vitae

Curriculum Vitae

Employment

Physician in private practice (2012–present)
A practice devoted entirely to drugs (www.doctorcaudevilla.com)
Primary care physician, Puerta Bonita I Health Centre (2002–2019)
Working part-time (2007–2011; 2014–2017; 2020–21) and on temporary contracts, carrying out the usual work of a health centre
Physician at juvenile justice centres (2002–2014)
Doctor in charge of the public centres run by the Justice Department of the Regional Government of Madrid for the rehabilitation of young offenders.

Education

University Expert in Drug Dependence (Complutense University of Madrid)
Specialist in Family and Community Medicine (Area X, INSALUD)
Degree in Medicine and Surgery

Teaching

Author of the module "Pharmacological approaches to addiction" on the Master’s in the Prevention and Treatment of Addictive Disorders, European University of Madrid (2023)
Lecturer on the Master’s in Drug Dependence, Autonomous University of Barcelona (IL-3) (2017–2022)
Classroom teaching over six editions, covering the modules "Intervention in educational institutions, with families, and in social, health and youth services"; "preventive
action in the media and the workplace"; and "community intervention" (38 ECTS)
Tutor on the course "An integrated approach to sexual health and drug use problems in the context of chemsex"
Tutor over six editions of this 75-hour online course (3 ECTS) for staff of drug treatment centres and HIV and STI testing centres. Author of the modules "Pharmacology" and "Risk and harm reduction"
Tutor on the "Sanidrogas" course, FAD (Foundation for Help against Drug Addiction) (2013–2017)
Tutor over five editions of this 50-hour online course, "Sanidrogas: nursing and primary care facing drug use problems", aimed at nursing professionals. Run by FAD and funded by the Spanish National Drugs Plan (PNSD). Accredited by the Continuing Education Commission for the Health Professions (National Health System).
Guest lecturer on the Master’s in Drug Dependence, Complutense Institute for Drug Dependence, Complutense University of Madrid (2006–2012)
Four-hour classroom sessions on "Synthetic drugs", "Risk and harm reduction", "Cannabis", "New psychoactive substances" and "Deep Web cryptomarkets"
Teaching at the semFYC update seminars (Spanish Society of Family and Community Medicine) (2006–2011)
Responsible for designing and delivering content across 22 training activities of 2, 4 or 8 hours for primary care physicians. Subjects: "Recreational cannabis use", "Therapeutic cannabis use", "An update on synthetic drugs", "Working with adolescents who use drugs", "Risk and harm reduction in recreational drug use", "Clinical interviewing techniques", "Managing cocaine use in primary care". Accredited by the Continuing Education Commission for the Health Professions (National Health System).
Teaching on a further 84 training activities (2004–2022):
Run by public institutions at European level (EMCDDA, European Monitoring Centre for Drugs and Drug Addiction), national level (PNSD, the Spanish National Drugs Plan), regional level (Madrid Anti-Drug Agency, Catalan Health Institute, Castilla-La Mancha Health Service, Castilla y León Health Department, Balearic Islands Health Service, Social Welfare Department of the Andalusian Government), municipal level (Madrid, Barcelona and Cádiz city councils), scientific societies (Spanish Society of Family and Community Medicine, Spanish Society of Primary Care Paediatrics, Spanish Association of Paediatrics, Spanish Society of Adolescent Medicine, SOCIDROGALCOHOL) and other private institutions in Spain and abroad.
The most frequent subjects have been "working with recreational drug use", "therapeutic cannabis use", "new synthetic drugs", "Deep Web cryptomarkets", "chemsex", "drugs and pregnancy" and "working with cannabis use"

Publications

Scientific publications

Martin Horton-Eddison M, Shortis P, Aldridge J, Caudevilla F. Drug Cryptomarkets in the 2020s:Policy, Enforcement, Harm, and Resilience. Policy Brief 16, June 2021ESTVIH group. A feasibility study for 3 strategies promoting HIV testing in primary health care in Madrid, Spain (ESTVIH project). J Eval Clin Pract. 2017 ;23:1408-1414.
Quintana P, Ventura M, Grifell M, Palma A, Galindo L, Fornís I, Gil C, Carbón X, Caudevilla F, Farré M, Torrens M. The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin. Int J Drug Policy. 2017 ;40:78-83
Caudevilla F, Ventura M, Fornís I, Barratt MJ, Vidal C, et al. Results of an international drug testing service for cryptomarket users. Int J Drug Policy. 2016; 22:38-41
Caudevilla F The emergence of deep web marketplaces: a health perspective. In: The internet and drug markets (European Monitoring Centre for Drugs and Drug Addiction: Insights 21) Publications Office of the European Union, Luxembourg 2016
Vale Pires C, Caudevilla Gálligo, F, Valente, H. . Netreach Work: Implementing Web-based Harm Reduction. Interventions with Online Drug Users. Adiktologie 2016; 2: 182-187
Caudevilla Gálligo F, Ventura M, Indave Ruiz BI, Fornís I. Presence and composition of cathinone derivatives in drug taken from a Drug Test Service in Spain (2010–2012) Hum. Psychopharmacol Clin Exp 2013; 28: 341–344
González D, Ventura M, Caudevilla F, Torrens M, Farré M Consumption of new psychoactive substances in a Spanish sample of research chemical users. Hum. Psychopharmacol Clin Exp 2013; 28: 332–340.
Fornís Espinosa I, Vidal Giné C, Caudevilla Gálligo F, Ventura Vilamala M. Nuevas drogas de síntesis en España: legal highs (2010-2012) Med Clin (Barc). 2013;140:189-90.
Caudevilla F, Quintana P, Fornís I, Ventura M Metanfetamina vendida como MDMA Emergencias 2013; 25: 150-160
Caudevilla F, Riba J, Ventura M, Gonzalez D, Farré M, Barbanoj MJ, Bouso JC. 4-Bromo-2,5- dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects J Psychopharmacol. 2012 9, 46-56
Ventura M, Caudevilla Gálligo F, Vidal Giné C, Grupo Investigadores SELECTO Cocaína adulterada con levamisol: posibles implicaciones clínicas. Medicina Clínica 2011 Mar 26;136:367-8.
Vidal C, Caudevilla F, Ventura M Análisis in situ de sustancias y adulteraciones Adicciones.2010;22:173-4.
Caudevilla F, González Fernández I, Cabrera A Actualización en cocaína Form Med Contin Aten Prim.2010; 17 :3-11
Caudevilla F Actualización en cannabis Form Med Contin Aten Prim. 2009;16:204-12
Caudevilla F, González Tardón P, Fenoll C. Novedades en drogas de síntesis Form Med Contin Aten Prim 2009;16(7):383-9
Caudevilla F, Cabrera A Efectos psicológicos del cannabis Form Med Contin Aten Prim. 2008;15:282-90
Zarco J, Caudevilla F Tratamiento del síndrome de abstinencia al alcohol y otras drogas Form Med Contin Aten Prim. 2007;14:40-6
Anoro M, Caudevilla F, Monfort N Abordaje del consumo de drogas: una propuesta de actuación desde la atención primaria AMF 2006;2(8):431-441
Caudevilla F, Anoro M, Monfort N Drogas de síntesis ¿qué podemos hacer? El Médico 2005; 975 27-42
Caudevilla F, Anoro M, Monfort N Alcohol ¿es suficiente la detección?. El Médico 2005; 974 29-40
Caudevilla, F ¿Qué quieren saber los usuarios de éxtasis?: Estudio en una lista de correo de Internet Adicciones 2005, 17. 97-104
Caudevilla, F, Bouso Saiz JC Éxtasis: ¿Inocuo o no? Med Clin 2005; 124:596-7
Caudevilla, F Ortells E Nuevas drogas FMC 2004; Supl 1: 46-51
Caudevilla, F. Investigación terapéutica con éxtasis Med Clin 2003 ; 121: 318-319
Caudevilla, F. El éxtasis, una revisión de la bibliografía científica sobre la MDMA Med Clin 2003; 120: 505-51

Books and book chapters:

Caudevilla F, Herranz C, Gonzalez I. “Consumo de otras drogas. Problemas y su tratamiento” en Hidalgo M, Rodríguez L, Muñoz T (Eds) “Medicina de la Adolescencia: Atención Integral” Ed. Ergon. Madrid, 2020
Caudevilla F. El consejo sanitario en el uso recreativo de drogas. En: Pérez Valero I, Blanco Arévalo JL (Eds). 99 preguntas clave sobre “chemsex”. Fundación GEIMC-CESIDA. Madrid,2017.
Dolengevich H, Caudevilla F, Ryan P. Drogas usadas para el ChemSex y sus acciones sobre el ser humano. En: Pérez Valero I, Blanco Arévalo JL (Eds). 99 preguntas clave sobre “chemsex”. Fundación GEIMC-CESIDA. Madrid, 2017.
Caudevilla F, Olano E. Reducción de riesgos y daños. En: Esteban A (Coord) Proyecto EVICT. Grupo de Trabajo para el Estudio y Abordaje de políticas de control del policonsumo de tabacoy alcohol en España. CNPT. Madrid, 2016
Caudevilla F “Shulgin, droga, ciencia y moral”. En Shulgin A Shulgin A TIHKAL. Ed Manuscritos Madrid 2016
Bouso JC, Caudevilla F Esteroides anabólico androgénicos y sustancias análogas. En; Martínez Oró DP, Pallarés Gómez J (Eds). De riesgos y placeres: manual para entender las drogas. Ed.Milenio, Barcelona 2013
Caudevilla F. Reducción de riesgos en el colectivo homosexual. En Martínez Oró DP, Pallarés Gómez J (Eds) De riesgos y placeres: manual para entender las drogas. Ed. MIlenio, Barcelona, 2013
Caudevilla F. Efectos y riesgos del uso de hongos psilocibes. En Bouso JC (Ed) Psilocibes. Ed. Ultrarradio. Barcelona, 2013
Caudevilla F, Ruiz Indave I, Calzada N, Zarco J. “Guía de Atención Sanitaria en Espacios de Ocio”. Energy Control (ABD). Barcelona, 2012
Caudevilla F, Zarco J, Camarelles F . “Conductas de riesgo adictivo” en “Tratado de Medicina Familiar y Comunitaria (2 ed). Ed Panamericana. Madrid, 2012
Caudevilla F, Zarco J. Educación Para la Salud en Tabaco, Alcohol y Otras Drogas en “Medicina del Adolescente: Atención Integral” (2 ed) Ed. Ergon. Madrid, 2012
(VV.AA) Drogas, algunas respuestas a tus preguntas sobre psicoactivos y otras sustancias Ed. Diagonal. Madrid, 2011
Caudevilla F. Efectos y riesgos de la cocaína. En (VV.AA) Pioneros de la coca y de la cocaína. Biblioteca Letras Psicoactivas. El Peón Espía. Madrid, 2011
Caudevilla F. Efectos y riesgos del cannabis. En (VV.AA) Cannabis. Ed. Amargord, Madrid 2007
(VV.AA) Actuar es posible: El papel de la Atención Primaria ante los problemas de salud relacionados con el consumo de drogas. Ed. semFYC. Barcelona 2007
Caudevilla F, González I “Drogodependencias: Guía de Práctica Clínica”. Ed. Ferrer; Barcelona, 2007
Caudevilla F. “Drogas:¿cómo afrontar el problema?” Exlibris Ediciones; Madrid, 2006
Zarco J, Caudevilla F, Casado V. “Atención a las personas con hábitos tóxicos y conductas de riesgo” en Medicina de Familia. Guía para Estudiantes. Editorial Ariel. Madrid, 2005
Caudevilla F. Éxtasis (MDMA). Ed.Amargord, Madrid 20055

Conference presentations:

International

Caudevilla F. Harm reduction and cryptomarkets. The final frontier? Club Health 2019. Amsterdam, 17 Jul 2019
Caudevilla F. Drugs and harm reduction. Nightlife et Consumation Récréatíve des Drogues. Lucerne 24 Ene 2019
Caudevilla,F. Doctor X: 5 years of harm reduction advice on darknet markets. Psychedelic Lessons, 2018 . Bratislava, Mayo 2018
Caudevilla F. “Cryptomarkets: just criminal settings or a new frontier for Harm Reduction?” Third European Conference on Addictive Behaviours and Dependencies - Lisbon Addictions 23 Oct 2019
Caudevilla F. Project CHEM-SAFE. An online harm reduction tool for chemsex users. Nights Conference 2018. 16 Nov 2018
Caudevilla F. How to deal with harm reduction without being prosecuted? The adventures of DoctorX in Deep Web. NIGHTS 2017 (STADT NACH ACHT) Berlin 9 Nov 2017
Caudevilla F. Deep Web, Narcotráfico on-line en el siglo XXI. 2º Congreso Internacional sobre Consumo Problemático de Drogas. 5 Oct 2017. Buenos Aires
Caudevilla F. The story of deep web Harm Reduction. Seminar on the New Psychoactive Substances. (NPS Care Project) Brussels 22 Sept 2017
Caudevilla F. Tráfico de drogas por Internet y ¿el fin del narcotráfico? Semana Psicoactiva de Bogotá. 24 June 2015 Bogotá Colombia
Caudevilla F. Cannabis: entre el uso medicinal y el abuso perjudicial Semana Psicoactiva de Bogotá. 23 June 2015 Bogotá Colombia
Caudevilla F Risk and Harm Reduction in Deep Web Boom Festival, Liminal Village. 14 Aug 2016
Caudevilla F New Psychoactive Substances (NPS) in Deep Web Marketplaces (DWM): Innovative approaches to New Psychoactive Substances New Psychoactive Substances Seminary, 18 Oct 2015 Lisbon
Caudevilla F Deep Web Marketplaces: an opportunity for Harm Reduction International Drug Reform Policy Conference.22 Nov 2015 Washington
Caudevilla F Internet, Undernet and Harm Reduction International Harm Reduction Conference 2015. 22 October 2015 Kuala Lumpur
Caudevilla, F The importance of NPS in online drug markets: data from Silk Road 2.0 Third international conference on novel psychoactive substances, 15 May 2014, Rome
Caudevilla F Subjective, adverse effects and presence of psychedelic phenethylamines (“2C-X”) in the recreational Spanish drug market (2006-2011) First International Congress on Novel Psychoactive Substances. 14 March 2012 Budapest

Spain:

Caudevilla F. Intervención en el adolescente consumidor de drogas. XXXVI Congreso de la Sociedad Española de Medicina de la Adolescencia. Madrid 8 Oct 22
Caudevilla F. El Consultorio del Dr. X: Asesoramiento para la reducción de riesgos del consumo de nuevas sustancias sintéticas" en el 1st Interational Congress. XLVI Jornadas Nacionales Socidrogalcohol , Malaga 7 Mar 2019
Caudevilla F. Chemsex: Realidad, mito y estigma.XLV Jornadas Nacionales Socidrogalcohol, Toledo 5 Mar 2018
Caudevilla F. Drogas y Sexo ¿Es posible la prevención? Congreso“Factores y conductas de riesgo asociadas a la identidad sexual y género”UNAD, 12 Jun 2018
Caudevilla F.Uso de drogas y su influencia en las prácticas sexuales:“chemsex” XXXV Congreso XXXXV Congreso AEDV(Asociación Española de Dermatología y Veneorología) . Madrid, 25 Marzo 2017
Caudevilla F. Intervención en Drogas. XXXVII Congreso de la semFYC Madrid,3 Marzo 2017
Caudevilla F.Alcohol y otras drogas ¿Cuándo sospechar y cómo actuar en la consulta?.XXX Congreso de la Sociedad Española de Medicina de la Adolescencia. Madrid 4 Abril 2016
M Grifell, L Galindo, P Quintana, A Palma, I Fornís, M Ventura, L González, F Caudevilla. Intervención on-line en consumidores de drogas que solicitan asesoramiento médico. Poster presentado en: XVIII Congreso Nacional de Psiquiatria. 24-26 Setiembre 2015, Santiago de Compostela
Caudevilla F. "Adolescentes y drogas” 61 Congreso de la Asociación Española de Pediatría 31 Junio 2012
Caudevilla F. Taller sobre uso recreativo de drogas. XXX. Congreso de la SEMFYC. VC
Caudevilla F. “Cannabis: ¿Qué debe saber el Médico de Familia?” XXIX Congreso de la SEMFYC. Barcelona, 26 Nov2009
Caudevilla F “Actualización en uso terapéutico del cannabis”. . XXVII Congreso de la SEMFYC. Madrid, 20 Nov 2008
Caudevilla F “Intoxicación por drogas de síntesis XXVI Congreso de la SEMFYC, Valencia, 17 Nov 06.Speaker at the
Caudevilla F. “Atención Primaria y Drogas”. XXII Congreso de la SEMFYC (Madrid, 20/11/02)

Other activities:

Medical adviser to the NGO Energy Control (ABD) (2001–2020)
Responsible, among other duties, for training volunteers, producing technical materials and giving online medical advice, and for coordinating and managing the "Energy Control International" (2013–2020) and "CHEM-SAFE" (2015–2019) projects
Member of the Chemsex Working Group of the Spanish National AIDS Plan, Ministry of Health (2016–2021)
Member of the Drug Intervention Group of semFYC (Spanish Society of Family and Community Medicine) (2005–present)